Extraordinary general meeting March 18th 2024

Extra bolagsstämma 27 februari 2024 ställs in

Brev till aktieägarna 2024-01-30

Redeye Growth Day June 2nd

Redeye initiating coverage

ISR in the podcast "Innovationslandet Sverige" – Corona vaccine in powder form

Sweden to seek BD's approval for human trial of nasal Covid jab

Wonder nasal vaccine knocking on the door

An Overview about ISR`s Vaccine Business – 1st Edition, 2022

Interview with ISR's CEO Ola Winqvist